Product Information
REFRESH DIGITAL EYE DROPS is a brand product labeled by Allergan, Inc., priced at $1.0323 per ML under NDC 00023695210. Its NADAC has been published 203 times since Oct 14, 2020.
Strength
5; 10; 5 mg/mL; mg/mL; mg/mL
Manufacturer
Allergan, Inc.NDC
00023695210
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80Approval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
8/1/2020
Pharmacological Classes
Price Statistics
The NADAC for REFRESH DIGITAL EYE DROPS has been published 203 times since Oct 14, 2020, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0323 per ML |
|---|---|
| All-time high | $1.0337 (Sep 10, 2025) |
| All-time low | $0.9806 (May 19, 2021) |
| 52-week high | $1.0337 |
| 52-week low | $1.0308 |
| Median price | $1.0316 |
| Average price | $1.0114 |
| Largest weekly change | +5.3% (Jun 19, 2024) |
| Weeks tracked | 203 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Carboxymethylcellulose sodium, Glycerin, Polysorbate 80 market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carboxymethylcellulose sodium, Glycerin, Polysorbate 80 market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH DIGITAL EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH DIGITAL EYE DROPS, manufactured by Allergan, Inc., is $1.0323 per ML (NDC 00023695210), effective Sep 30, 2026.
How has the price of REFRESH DIGITAL EYE DROPS changed over time?
Over the history we have for it, the NADAC for REFRESH DIGITAL EYE DROPS has risen 5.2%. It has been tracked across 203 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for REFRESH DIGITAL EYE DROPS?
Since Oct 14, 2020, the NADAC for REFRESH DIGITAL EYE DROPS has ranged from a low of $0.9806 (May 19, 2021) to a high of $1.0337 (Sep 10, 2025), with a median of $1.0316 per ML.
Are there cheaper alternatives to REFRESH DIGITAL EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of REFRESH DIGITAL EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REFRESH DIGITAL EYE DROPS?
REFRESH DIGITAL EYE DROPS (NDC 00023695210) is labeled by Allergan, Inc., and CMS classifies it as a brand product.